Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics

Journal of Steroid Biochemistry and Molecular Biology

Volumn 116, Issue 1-2, 2009, Pages 37-43

  Genin, Emmanuelle C ^a,b   Gondcaille, Catherine ^a,b   Trompier, Doriane ^a,b   Savary, Stéphane ^a,b  

^a Chu   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

ABC transporters; Adrenoleukodystrophy; Gene expression; Peroxisome; Thyroid hormone

Indexed keywords

LIOTHYRONINE; THYROID HORMONE RECEPTOR BETA;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FIBROBLAST; GENE INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PARALOGY; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; X CHROMOSOME LINKED DISORDER;

ACETIC ACIDS; ADRENOLEUKODYSTROPHY; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CERCOPITHECUS AETHIOPS; COS CELLS; GLYOXYLATES; HUMANS; PHENOLS; RATS; THYROID HORMONES; TRANSFECTION; TRIIODOTHYRONINE; UP-REGULATION;

MUS; RATTUS; RODENTIA;

EID: 67549132513     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.04.006     Document Type: Article

References (49)

1. Moser H.W., Smith K.D., Watkins P.A., Powers J., and Moser A.B. X-linked adrenoleukodystrophy. In: Scriver R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic & Molecular Bases of inherited Disease. eighth (2001), McGraw-Hill Book Co., New York 3257-3301
2. Berger J., and Gartner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763 12 (2006) 1721-1732
3. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P., and Putative. X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 6414 (1993) 726-730
4. Lombard-Platet G., Savary S., Sarde C.O., Mandel J.L., and Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc. Natl. Acad. Sci. U.S.A. 93 3 (1996) 1265-1269
5. Kamijo K., Taketani S., Yokota S., Osumi T., and Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J. Biol. Chem. 265 8 (1990) 4534-4540
6. Holzinger A., Kammerer S., and Roscher A.A. Primary structure of human PMP69, a putative peroxisomal ABC-transporter. Biochem. Biophys. Res. Commun. 237 1 (1997) 152-157
7. Shani N., Jimenez-Sanchez G., Steel G., Dean M., and Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. Hum. Mol. Genet. 6 11 (1997) 1925-1931
8. Kashiwayama Y., Seki M., Yasui A., Murasaki Y., Morita M., Yamashita Y., Sakaguchi M., Tanaka Y., and Imanaka T. 70-kDa peroxisomal membrane protein related protein (P70R/ABCD4) localizes to endoplasmic reticulum not peroxisomes, and NH2-terminal hydrophobic property determines the subcellular localization of ABC subfamily D proteins. Exp. Cell. Res. 315 2 (2009) 190-205
9. Braiterman L.T., Zheng S., Watkins P.A., Geraghty M.T., Johnson G., McGuinness M.C., Moser A.B., and Smith K.D. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum. Mol. Genet. 7 2 (1998) 239-247
10. Flavigny E., Sanhaj A., Aubourg P., and Cartier N. Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy. FEBS Lett. 448 2-3 (1999) 261-264
11. Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., and Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum. Mol. Genet. 8 5 (1999) 907-913
12. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pampols T., Giros M., and Mandel J.L. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13 23 (2004) 2997-3006
13. Albet S., Causeret C., Bentejac M., Mandel J.L., Aubourg P., and Bugaut M. Fenofibrate differently alters expression of genes encoding ATP-binding transporter proteins of the peroxisomal membrane. FEBS Lett. 405 3 (1997) 394-397
14. Kemp S., Wei H.M., Lu J.F., Braiterman L.T., McGuinness M.C., Moser A.B., Watkins P.A., and Smith K.D. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4 11 (1998) 1261-1268
15. Fourcade S., Savary S., Albet S., Gauthe D., Gondcaille C., Pineau T., Bellenger J., Bentejac M., Holzinger A., Berger J., and Bugaut M. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. Eur. J. Biochem. 268 12 (2001) 3490-3500
16. Bugaut M., Fourcade S., Gondcaille C., Gueugnon F., Depreter M., Roels F., Netik A., Berger J., Martin P., Pineau T., Cadepond F., El Etr M., and Savary S. Pharmacological induction of redundant genes for a therapy of X-ALD: phenylbutyrate and other compounds. Adv. Exp. Med. Biol. 544 (2003) 281-291
17. Gondcaille C., Depreter M., Fourcade S., Lecca M.R., Leclercq S., Martin P.G., Pineau T., Cadepond F., Eletr M., Bertrand N., Beley A., Duclos S., De Craemer D., Roels F., Savary S., and Bugaut M. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J. Cell Biol. 169 (2005) 93-104
18. Fourcade S., Savary S., Gondcaille C., Berger J., Netik A., Cadepond F., El Etr M., Molzer B., and Bugaut M. Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2). Mol. Pharmacol. 63 6 (2003) 1296-1303
19. Gueugnon F., Gondcaille C., Leclercq S., Bellenger J., Bellenger S., Narce M., Pineau T., Bonnetain F., and Savary S. Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents. Biochimie 89 11 (2007) 1312-1321
20. Just W.W., and Hartl F.U. Rat liver peroxisomes, II. Stimulation of peroxisomal fatty-acid beta-oxidation by thyroid hormones. Hoppe Seylers Z. Physiol. Chem. 364 11 (1983) 1541-1547
21. Hartl F.U., and Just W.W. Integral membrane polypeptides of rat liver peroxisomes: topology and response to different metabolic states. Arch. Biochem. Biophys. 255 1 (1987) 109-119
22. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 3 (2001) 1097-1142
23. Yen P.M., Ando S., Feng X., Liu Y., Maruvada P., and Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol. Cell. Endocrinol. 246 1-2 (2006) 121-127
24. Zhang J., and Lazar M.A. The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62 (2000) 439-466
25. Bianco A.C., and Kim B.W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 116 10 (2006) 2571-2579
26. Scanlan T.S., Yoshihara H.A., Nguyen N.H., and Chiellini G. Selective thyromimetics: tissue-selective thyroid hormone analogs. Curr. Opin. Drug Discov. Dev. 4 5 (2001) 614-622
27. Malm J., Grover G.J., and Farnegardh M. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor. Mini Rev. Med. Chem. 7 1 (2007) 79-86
28. Chiellini G., Apriletti J.W., Yoshihara H.A., Baxter J.D., Ribeiro R.C., and Scanlan T.S. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem. Biol. 5 6 (1998) 299-306
29. Taylor A.H., Stephan Z.F., Steele R.E., and Wong N.C. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol. Pharmacol. 52 3 (1997) 542-547
30. Trost S.U., Swanson E., Gloss B., Wang-Iverson D.B., Zhang H., Volodarsky T., Grover G.J., Baxter J.D., Chiellini G., Scanlan T.S., and Dillmann W.H. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141 9 (2000) 3057-3064
31. Baxter J.D., Webb P., Grover G., and Scanlan T.S. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol. Metab. 15 4 (2004) 154-157
32. Johansson L., Rudling M., Scanlan T.S., Lundasen T., Webb P., Baxter J., Angelin B., and Parini P. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc. Natl. Acad. Sci. U.S.A. 102 29 (2005) 10297-10302
33. Morte B., Manzano J., Scanlan T., Vennstrom B., and Bernal J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc. Natl. Acad. Sci. U.S.A. 99 6 (2002) 3985-3989
34. Perra A., Simbula G., Simbula M., Pibiri M., Kowalik M.A., Sulas P., Cocco M.T., Ledda-Columbano G.M., and Columbano A. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J. 22 8 (2008) 2981-2989
35. Weinhofer I., Kunze M., Rampler H., Forss-Petter S., Samarut J., Plateroti M., and Berger J. Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression. Eur. J. Cell. Biol. 87 12 (2008) 933-945
36. Timmer D.C., Bakker O., and Wiersinga W.M. Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA. J. Endocrinol. 179 2 (2003) 217-225
37. Suzuki S., Miyamoto T., Opsahl A., Sakurai A., and DeGroot L.J. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1. Mol. Endocrinol. 8 3 (1994) 305-314
38. Kester M.H., Kuiper G.G., Versteeg R., and Visser T.J. Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 147 12 (2006) 5845-5854
39. St Germain D.L., and Galton V.A. The deiodinase family of selenoproteins. Thyroid 7 4 (1997) 655-668
40. Asheuer M., Bieche I., Laurendeau I., Moser A., Hainque B., Vidaud M., and Aubourg P. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 14 10 (2005) 1293-1303
41. Wada Y., Matsubara S., Dufresne J., Hargrove G.M., Stephan Z.F., Steele R.E., and Wong N.C. Effects of a thyromimetic on apolipoprotein B-100 in rats. J. Mol. Endocrinol. 25 3 (2000) 299-308
42. Bengoechea-Alonso M.T., and Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell Biol. 19 2 (2007) 215-222
43. Weinhofer I., Kunze M., Rampler H., Bookout A.L., Forss-Petter S., and Berger J. Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation. J. Biol. Chem. 280 50 (2005) 41243-41251
44. Weinhofer I., Forss-Petter S., Zigman M., and Berger J. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 11 22 (2002) 2701-2708
45. Janssen A., Gressens P., Grabenbauer M., Baumgart E., Schad A., Vanhorebeek I., Brouwers A., Declercq P.E., Fahimi D., Evrard P., Schoonjans L., Collen D., Carmeliet P., Mannaerts G., Van Veldhoven P., and Baes M. Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J. Neurosci. 23 30 (2003) 9732-9741
46. Baas D., Puymirat J., and Sarlieve L.L. Posttranscriptional regulation of oligodendroglial thyroid hormone (T3) receptor beta 1 by T3. Int. J. Dev. Neurosci. 16 6 (1998) 461-467
47. Sarlieve L.L., Rodriguez-Pena A., and Langley K. Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage. Neurochem. Res. 29 5 (2004) 903-922
48. Baas D., Legrand C., Samarut J., and Flamant F. Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors. Proc. Natl. Acad. Sci. U.S.A. 99 5 (2002) 2907-2911
49. Jones S.A., Jolson D.M., Cuta K.K., Mariash C.N., and Anderson G.W. Triiodothyronine is a survival factor for developing oligodendrocytes. Mol. Cell. Endocrinol. 199 1-2 (2003) 49-60